Indian Army Medicines & Medical Supplies Tender 2026 Khadki Maharashtra - Bulk Pharmaceutical & OTC Products 2026

Tender Overview

The Indian Army (Department Of Military Affairs) invites bids for a broad range of pharmaceutical and healthcare products, including tablets, capsules, syrups, injections, ointments and respiratory solutions. The procurement covers 58 items across multiple therapeutic categories, with an estimated total quantity likely governed by an option clause. The Estimated Value is not disclosed, while the EMD is listed as ₹76. Deliveries are to The Commandant, MH Khadki, with coordination through the buyer’s approved design drawings. This tender emphasizes adherence to buyer-specified drawings and regulatory compliance for health products. The unique scope lies in assembling a large, diversified catalog of medicines and medical consumables under a single government contract, requiring robust supplier capacity and regulatory alignment. The tender signals an OEM-capable supplier base and compliance with government procurement terms, including quantity variation up to 25% and extension rules tied to delivery periods. The award will hinge on technical alignment with the buyer’s requirements and reliable supply chain readiness.

Key differentiators include mandatory Detailed Design Drawings approval within 5 days of award, a 7-day turn-around for modification lists, and a delivery framework that accommodates approval delays without LD. Bidders must ensure financial soundness and GST compliance. The scope is highly notional in the absence of explicit product-level specifications, but the breadth suggests a need for diversified manufacturing and distribution capabilities in the pharmaceutical sector.

Overall, this tender offers a structured opportunity to supply varied healthcare products to a defense segment, with defined administrative steps and conditional delivery timelines that bidders must manage carefully.

Technical Specifications & Requirements

• No itemized technical specifications are provided in the tender data; however, the scope includes a wide range of pharmaceutical forms (tablets, capsules, syrups, injections, suspensions, gels, and inhalation solutions) and supportive medical products.
• The Buyer requires Detailed Design Drawings (DDDs) to be prepared and approved within 5 days of award, with a 7-day window for modification lists. Non-approval delays may adjust delivery timelines without LD.
• The delivery location is The Commandant, MH Khadki, and installation/commissioning (if covered) occurs there.
• Experience criteria specify that the bidder or its OEM must have at least 3 years of regular supply to Central/State Govt Organizations or PSUs for similar categories.
• The tender includes a 25% quantity variation provision at contract placement and during currency, at contracted rates.
• The Terms require the bidder to submit PAN, GSTIN, cancelled cheque, and EFT mandate for vendor code creation.
• GST applicability is at bidder’s discretion, with reimbursement to be actuals or applicable rates, capped by the quoted GST percentage.
• A detailed compliance framework with government procurement terms and risk-sharing in delivery timelines is expected.

Terms, Conditions & Eligibility

• EMD amount listed as ₹76 (payment terms not fully disclosed); bidders must confirm EMD submission modality.
• Delivery period can be extended via option clause; extension calculation is (additional quantity/original quantity) × original delivery period, minimum 30 days.
• Post-award, bidders must provide Detailed Design Drawings within 5 days, with a 7-day modification list response; drawing approval or modification list provided by buyer within 7 days.
• The organization requires bidder financial integrity: no liquidation or court proceedings; must upload an undertaking.
• Bidder must show GST registration and PAN, plus a cancelled cheque and EFT mandate for vendor code creation.
• Experience: 3 years of producing and supplying similar category products to government bodies.